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A microarray experiment typically results in many thousands of measurements, each relating to the expression level of a single gene. Single genes, however, are often not the primary theoretical focus of the researcher, who might be more interested in certain pathways or genomic regions that are suspected to be biologically relevant. For this reason we have introduced the Global Test for groups of genes (1) , which allows the unit of analysis of the microarray experiment to be shifted from the single gene level to the pathway level, where a "pathway'' may be any set of genes, e.g. chosen using the Gene Ontology database or from earlier experiments. For every pathway, the Global Test can test (with a single test) whether the expression profile of that pathway is significantly associated with a clinical variable of interest. This allows researchers to immediately test theoretical hypotheses on the clinical importance of certain pathways. Even when such hypotheses are not directly available from biological theory or past research, the Global Test can significantly reduce the multiple testing problem, because there are typically much fewer pathways than genes. In the original publication of the Global Test, the clinical variable could be either a continuous measurement or a 0/1 group indicator. Recently, however, there has been a surge of interest in survival time of patients as the primary clinical outcome in a microarray experiment. Many of these studies focus on prediction of survival, e.g. in breast cancer (2-4) and in lung cancer (5, 6) . Other studies use multiple testing methods to find genes which are associated with survival (7) . The present paper extends the Global Test methodology to survival outcomes. It allows the researcher to test whether the expression profile of a given set of genes is associated with survival. More precisely it tests whether individuals with a similar gene expression profile tend to have similar survival times. A significant pathway may be a mix of genes which are upregulated for patients with short survival time, genes which are downregulated for the same patients, and other genes that show no association with survival at all. The test of the present paper is based on the Cox proportional hazards model. Therefore it avoids the requirement of many analysis strategies to choose an arbitrary cut-off (e.g. five years survival), but uses all survival information that is present in the data. Technically, the test is derived from the goodness-of-fit test of (8) . The original Global Test was derived in a similar way from a goodness-of-fit test for generalized linear models (9) . The two Global Tests are therefore highly comparable and allow quite similar interpretations. In this paper we also show how the test can be adjusted for the presence of covariates (possible confounders or competing risk factors). This allows better use of the Global Test in observational studies. Furthermore, it allows the researcher to establish that the microarray really adds something to the predictive performance of known risk factors, showing that it is not simply an expensive way to measure risk factors already known. It also allows the test to be used on more complex designs than a simple one-sample follow up study. The new Global Test method presented in this paper has been incorporated into the R-package globaltest, version 3.0, which is available from http://www.bioconductor.org.
The approach will be illustrated on a data set of 17 osteosarcoma patients, testing pathways from the Gene Ontology database.
the model
The Global Test exploits the duality between association and prediction. By definition, if two things are associated, knowing one improves prediction of the other. Hence, if survival is associated with gene expression profile, this means that knowing the gene expression profile allows a better prediction of survival than not knowing the expression profile. With this idea in mind we make a prediction model for prediction of survival from the gene expression measurements. The most convenient choice for such a model is the Cox proportional hazards model, which is the most widely used model for survival data in medical research. The Cox model uses the full empirical distribution of the survival times and it can handle censored data, i.e. samples for which the exact survival time is not known, but for which it is only known that the patient is still alive at a certain moment (10) . The use of the Cox model requires a true follow-up study design, meaning that patients were not selected on their survival times in any way. If such a patient selection was made, the methods of this paper may not be appropriate: in VantVeer (2), for example, where a selected group of early metastases was compared to a selected group which was at least five years metastasis-free, the original Global Test for a 0/1 outcome is preferable (1) . Suppose the matrix of normalized gene expression measurements for the group of genes of interest is given by the n × m matrix X with elements x ij , where n is the sample size and m the number of genes in the group. Suppose also that there is a number p ≥ 0 of covariates for each patient, which we put in an n × p data matrix Z with elements z ij . It will be assumed that p < n, but no such restriction is put on m. Cox's proportional hazards model (10) 
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In the context of testing it is most insightful to view the prior distribution of the regression coefficients as the focus of the power of the test. The test that will be derived in the next section will be a score test, which has the property that it has optimal power against alternatives with small values of the parameter τ 2 . This property stems from the fact that the score test is equivalent to the likelihood ratio test in the limit where the alternative τ 2 → 0 (Cox and Hinkley, 1974) . Alternatives with small values of τ 2 tend to have small values of �β 2 i , so that the test can be said to be optimal on average against alternatives with small values of �β 2 i . These alternatives are mainly alternatives which have all or most regression coefficients non-zero but small. The test can therefore be said to be optimized against alternatives in which all or most genes have some association with the outcome. This alternative is precisely the situation in which we are interested, because we want to say something about the pathway as a whole.
Alternative tests can easily be derived for regression coefficients with a more complex covariance structure. If the vector β = (β 1 , . . . , β m )
� is assumed a priori to have mean zero and covariance matrix τ 2 �, the resulting test of H 0 would be optimal against alternatives with small values of β � � β. The standard choice of � = I m distributes power equally over all directions of β, while a different choice will have more power against deviations from H 0 in directions which correspond to the larger eigenvalues of �. This property could be exploited in the derivation of a test for a specific purpose or to incorporate prior knowledge. In this paper we shall restrict ourselves to � = I m .
DERIVATION OF THE TEST
Testing the association of a group of genes with survival can therefore be done by testing H 0 in the empirical Bayesian model (1) with random regression coefficients. In this section we will derive the test statistic for this test. A score test for the same model has also been studied by Verweij et al. (1998) in the context of testing the fit of the Cox model. Their derivation was based on the partial likelihood of the Cox model. In this paper we give an alternative derivation based on the full likelihood and a simpler martingale argument.
We derive the test in stages. First suppose that all parameters , relating to the covariates. The hazard function determines the survival function ) (t S i , which gives the probability that individual i survives up to time t , through
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DERIVATION OF THE TEST
Testing the association of a group of genes with survival can therefore be done by testing H 0 in the empirical Bayesian model (1) with random regression coefficients. In this section we will derive the test statistic for this test. A score test for the same model has also been studied by Verweij et al. (1998) 
derivAtion of the test
Testing association of a group of genes with survival can therefore be done by testing 0 H in the empirical Bayesian model (1) with random regression coefficients. In this section we will derive the test statistic for this test. A score test for the same model has also been studied by Verweij (8) in the context of testing the fit of the Cox model. Their derivation was based on the partial likelihood of the Cox model. In this paper we give an alternative derivation based of the full likelihood and a simpler martingale argument. We derive the test in stages. First suppose that all parameters except
where
that all regression coefficients relating to the gene expressions are zero. If m were always small, we could test H 0 using classical tests which were developed for the Cox model. These tests do not work for general m, however (for an overview of these classical tests see Klein and Moeschberger, 1997, Section 8.2).
To obtain a test that works whatever the value of m, we put an extra assumption on the regression coefficients β 1 , . . . , β m . We assume that the regression coefficients of the genes are random and a priori independent with mean zero and common variance τ 2 . The null restrict ourselves to � = I (Tibshirani, 1997) . Both models can also be used to predict survival times of patients.
DERIVATION OF
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Testing the association of a group of genes with survival can therefore be done by testing H 0 in the empirical Bayesian model (1) and the baseline hazard function ) (t h are known. In this simplified situation it will be relatively easy to derive the score test, which can be generalized to the situation with unknown parameters later in this section.
the basic score test
By definition a score test is based on the derivative of the log-likelihood at the value of the parameter to be tested. Suppose for each individual i we have observed a survival time i t and a status indicator i d , where
indicates death (the patient died at i t ) and 0 = i d censoring (the patient was lost to follow-up at i t ). The loglikelihood of Chapter 8) assumes the hazard function at time t for individual i to relate to the covariates as
ds is the cumulative hazard up to time t. In this model, showing that the gene expressions are associated with survival is equivalent to rejecting the null hypothesis
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By definition a score test is based on the derivative of the loglikelihood at the value of the parameter to be tested. Suppose for each individual i we have observed a survival time t i and a status indicator d i , where d i = 1 indicates death (the patient died at t i ) and d i = 0 indicates censoring (the patient was lost to follow-up at t i ). The log-likelihood of τ 2 in model (1) is
is the contribution to the log-likelihood of individual i for fixed r i , and 
For the Cox model this becomes
where For known H (t) and known c 1 , . . . , c n , expression (3) can be standardized to have unit variance and be used as the score test statistic. When these parameters are unknown, we must plug in maximum likelihood estimates for them under the null model in which τ 2 = 0. Standardizing the score test is traditionally done using the Fisher information, calculated from the second derivatives of the loglikelihood. In this case these calculations are very unpleasant, and it turns out to be simpler to standardize using the estimated variance
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where u i = e ci H (t i ), i = 1, . . . , n, is the hazard incurred by individual i up to time t i . Note that d i − u i is the martingale residual of individual i at time t i (Klein and Moeschberger, 1997, Section 11.3).
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We shall first plug in the estimate for the cumulative hazard H (t), but still assume that γ 1 , . . . , γ p and hence c 1 , . . . , c n are known. As the maximum likelihood estimate of H (t) we can take the Breslow estimator (Klein and Moeschberger, 1997, Section 8.6)
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Testing the association of a group of genes with survival can therefore be done by testing H 0 in the empirical Bayesian model (1) (Tibshirani, 1997 ). Both models can also be used to predict survival times of patients.
Alternative tests can easily be derived for regression coefficients with a more complex covariance structure. If the vector β = (β 1 , . . . , β m ) � is assumed a priori to have mean zero and covariance matrix τ 2 �, the resulting test of H 0 would be optimal against alternatives with small values of β � � β. The standard choice of � = I m distributes power equally over all directions of β, while a different choice will have more power against deviations from H 0 in directions which correspond to the larger eigenvalues of �. This property could be exploited in the derivation of a test for a specific purpose or to incorporate prior knowledge. In this paper we shall restrict ourselves to � = I m .
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Using estimated regression coefficients
The expectation of T 0 can be estimated using the formulas in Section 3.2. They are approximatelŷ = (r 1 , . . . , r n ) � , the vector of the linear effects of the gene expressions. This r has mean zero and covariance matrix τ 2 R, where R = XX � . For the general likelihood (2) and an r of this form, Le Cessie and Van Houwelingen (1995) have used a Taylor approximation to derive
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To evaluateÊT 0 and � Var(T 0 ) we replace the parameter values of γ 1 , . . . , γ p by their estimates. Simulations in Verweij et al. (1998) show this approximation to be quite accurate. = (r 1 , . . . , r n ) , the vector of the linear effects of the gene expressions. This r has mean zero and covariance matrix τ 2 R, where R = XX � . For the general likelihood (2) and an r of this form, Le Cessie and Van Houwelingen (1995) have used a Taylor approximation to derive
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In general the regression coefficients γ 1 , .
are not known but must be estimated. Repla maximum likelihood estimates will still gi H 0 , but with a different distribution of th the following approximation to this distrib by Verweij et al. (1998) . The estimated martingale residuals d −ũ γ 1 , . . . ,γ p can be approximated in a first ord by
data matrix of the fixed covariates. Therefor statistic T 0 can be approximated as
The expectatio using the formulas in Section 3.2. They are . . , γ p of the covariates are not assumed to be random. The Cox model with random coefficients is an empirical Bayesian model and is closely linked to penalized likelihood methods. It should be noted that we have not assumed a specific distributional form for the regression coefficients; the derivation of our test is invariant to the choice of the shape of this distribution. Choosing a Gaussian distribution results in a Cox ridge regression model (Pawitan et al., 2004) ; choosing a double exponential distribution results in a LASSO model (Tibshirani, 1997) . Both models can also be used to predict survival times of patients.
In the context of testing it is most insightful to view the prior distribution of the regression coefficients as the focus of the power of the test. The test that will be derived in the next section will be a score test, which has the property that it has optimal power against alternatives with small values of the parameter τ 2 . This property stems from the fact that the score test is equivalent to the likelihood ratio test in the limit where the alternative by their estimates. Simulations in Verweij (8) show this approximation to be quite accurate.
the distribution of the test statistic
There are two ways to calculate the p-value of the test: by asymptotic theory and by permutation arguments. We outline both options and their advantages. In equation (7.5) it will be shown that the centered test statistic
The distribution of the test statistic
There are two ways to calculate the P -value of the test: by theory and by permutation arguments. We outline both and their advantages.
Equation (9) in Section 3.5 it will be shown that the c statistic T −ÊT can be written as a linear combination o gales. Therefore by the martingale central limit theorem et al., 1993) the distribution of the standardized Q con standard normal distribution as n → ∞. This fact m use of a normal approximation to the distribution of Q the one-sided P -value (see also simulation results by Ve 1998). Interesting simulations which give insight in to of the score test in a random effects survival model a Andersen et al. (1999) .
For small samples the asymptotic distribution may no enough. An alternative is to calculate Q for all, or a rand of many (10 000), permutations of the martingale residu samples. This randomly redistributes the vectors of gene measurements over the individuals, while keeping the between the fixed covariates and survival the same. The re can be written as a linear combination of n martingales. Therefore by the martingale central limit theorem (13) the distribution of the standardized Q converges to a standard normal distribution as Testing association of a pathway with survival distribution of the test statistic wo ways to calculate the P -value of the test: by asymptotic by permutation arguments. We outline both the options dvantages.
(9) in Section 3.5 it will be shown that the centered test −ÊT can be written as a linear combination of n martinefore by the martingale central limit theorem (Andersen 3) the distribution of the standardized Q converges to a ormal distribution as n → ∞. This fact motivates the rmal approximation to the distribution of Q to calculate ed P -value (see also simulation results by Verweij et al., resting simulations which give insight in to the power re test in a random effects survival model are given in t al. (1999) . ll samples the asymptotic distribution may not be reliable n alternative is to calculate Q for all, or a random sample 0 000), permutations of the martingale residuals of the n his randomly redistributes the vectors of gene expression nts over the individuals, while keeping the relationship possible we will drop the dependence on time for convenience of notation.
Note that the compensator ofˆ is , which is also the compensator of N.
� ) dN is a martingale vector. Subtracting the intensities and writing M = N − ,
The statistic T is T (∞) with
From the integration by parts formula (Fleming and Harrington, 1991, Theorem A.1.2) it follows that, almost surely,
This fact motivates the use of a normal approximation to the distribution of Q to calculate the one-sided p-value [see also simulation results by Verweij (8) . Interesting simulations which give insight in the power of the score test in a random effects survival model are given in Andersen (13) .
For small samples the asymptotic distribution may not be reliable enough. An alternative is to calculate Q for all, or a random sample of many (10,000), permutations of the martingale residuals of the n samples. This randomly redistributes the vectors of gene expression measurements over the individuals, while keeping the relationship between the fixed covariates and survival the same. The resulting distribution is another approximation to the null distribution of Q , which can be used to find the p-value. Use of the permutation null distribution requires the assumption that there is no relationship between the gene expressions on the one hand and the covariates and the censoring mechanism on the other hand: permuting destroys these associations. This makes the permutation null distribution less useful when covariates are present. The main advantage of the permutation-based p-value is that it gives an "exact'' p-value, which is guaranteed to keep the alpha level provided enough permutations are used. This is especially useful for smaller sample sizes, where we may not trust the normality of the distribution of Q . The advantage of the asymptotic theory p-value---aside from being much quicker to calculate---is that it has more power: the permutation based p-value does not use the full null distribution, but the null distribution conditional on the set of observed martingale residuals. With this conditioning the test loses some power, as the set of observed residuals is informative for the parameter the one-sided P -value (see also simulation results by Verweij et al., 1998) 
For small samples the asymptotic distribution may not be reliable enough. An alternative is to calculate Q for all, or a random sample of many (10 000), permutations of the martingale residuals of the n samples. This randomly redistributes the vectors of gene expression measurements over the individuals, while keeping the relationship between the fixed covariates and survival the same. The resulting distribution is another approximation to the null distribution of Q, which can be used to find the P -value. Use of the permutation null distribution requires the assumption that there is no relationship between the gene expressions on the one hand and the covariates and the censoring mechanism on the other hand: permuting destroys these associations. This makes the permutation null distribution less useful when covariates are present.
The main advantage of the permutation-based P -value is that it gives an 'exact' P -value, which is guaranteed to keep the alpha level provided enough permutations are used. This is especially useful for smaller sample sizes, where we may not trust the normality of the distribution of Q. The advantage of the asymptotic theory Pvalue-aside from being much quicker to calculate-is that it has more power: the permutation based P -value does not use the full null distribution, but the null distribution conditional on the set of observed martingale residuals. With this conditioning the test loses some power, as the set of observed residuals is informative for the parameter τ 2 .
Counting process calculations
In this technical section we calculate the mean and variance of the test statistic T under the null hypothesis for known c 1 , . . . , c n but estimated H (t), as given in Equations (5) and (6) . For this we will use a counting process notation (Fleming and Harrington, 1991; Andersen et al., 1993). The strategy we will use is common in martingale theory: we write our test statistic T as the limit of a process T (t) as t → ∞ and decompose T (t) into a martingale and a compensator. The limit of the compensator is the estimator of the mean of T and the limit of the predictable variation process is the estimate of the variance. For an alternative derivation, see Verweij et al. (1998) .
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and some line 
In this technical section we calculate the mean and variance of the test statistic T under the null hypothesis for known
Let
From the integration by parts formula (Fleming and Harri 1991, Theorem A.1.2) it follows that, almost surely,
where M − (s) = M(s−) is a predictable process. Using Equat and some linear algebra we can say that, almost surely,
The process S = T −ÊT is a martingale. It can be written following way:
as the integral of the predictable process vector
over the martingale vector M. The predictable variation proc S is therefore �S� = t 0 diag(KK � ) � d , which we can estimat
To evaluateÊT and Var(T ) we use
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where M − (s) = M(s−) is a predictable process. Using Equation (8) and some linear algebra we can say that, almost surely,
The process S = T −ÊT is a martingale. It can be written in the following way:
over the martingale vector M. The predictable variation process of S is therefore �S� = t 0 diag(KK � ) � d , which we can estimate by
Writing P for the n × n matrix with elements p ij and M for the n × n matrix with elements m ij , the results (5) and (6) follow.
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From the integration by parts formula (Fleming and Harrington, 1991, Theorem A.1.2) it follows that, almost surely, Note that the compensator ofˆ is , which is also the compensator of N.
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Writing P for the n × n matrix with elements p ij and M for the n × n matrix with elements m ij , the results (5) and (6) Note that the compensator ofˆ is , which is also the compensator of N.
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Writing P for the n × n matrix with elements p ij and M for the n × n matrix with elements m ij , the results (5) and (6) There are two ways to calculate the P -value of the test: by asymptotic theory and by permutation arguments. We outline both the options and their advantages. Equation (9) in Section 3.5 it will be shown that the centered test statistic T −ÊT can be written as a linear combination of n martingales. Therefore by the martingale central limit theorem (Andersen et al., 1993 ) the distribution of the standardized Q converges to a standard normal distribution as n → ∞. This fact motivates the use of a normal approximation to the distribution of Q to calculate the one-sided P -value (see also simulation results by Verweij et al., 1998) . Interesting simulations which give insight in to the power of the score test in a random effects survival model are given in Andersen et al. (1999) .
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where M − (s) = M(s−) is a predictable process. Using Equation (8) and some linear algebra we can say that, almost surely, The process S = T −ÊT is a martingale. It can be written in the following way:
over the martingale vector M. The predictable variation process of S is therefore �S� = Writing P for the n × n matrix with elements p ij and M for the n × n matrix with elements m ij , the results (5) and (6) follow. The process S = T −ÊT is a martingale. It can be written in the following way:
over the martingale vector M. The predictable variation process of S is therefore �S� = Writing P for the n × n matrix with elements p ij and M for the n × n matrix with elements m ij , the results (5) and (6) Note that the compensator ofˆ is , which is also the compensator of N. Write M = N −ˆ . Then d −û = M(∞) and M(t) = t 0 (I − V1 � ) dN is a martingale vector. Subtracting the intensities and writing M = N − ,
interpretAtion
When testing a specific pathway for a specific sample of patients, it is usually not satisfactory to only report the resulting p-value. In this section we will discuss some issues related to interpretation of the test result. We show how to calculate and visualize the influence of individual genes on the test result. We also propose an diagnostic which can be used when many genes are associated with survival, to assess whether a gene group is exceptional. We only give the theory here; for an example see section 9.
interpretation The test of this paper is derived from the Cox model in the same way as the Global Test in Goeman (1) was derived from the generalized linear model. The functional form of the test statistic is therefore quite similar, the martingale residuals taking the place of the residuals from the generalized linear model in that paper. Much of the interpretation of the test statistic is therefore also quite similar. Central to all interpretation of the test outcome is the matrix R = XX´ which figures prominently in the formula for the test statistic. It is an n × n matrix which can be seen as describing the similarities in expression profile between the samples. The entry ij R is relatively large if samples i and j have a relatively similar expression profile over the pathway of interest.
To show the role of the matrix R , we can rewrite the unstandardized test statistic 0 T as Fig. 1 . Gene plot of microtubule cytoskeleton pathway, showing the sorted Global Test statistics for testing t pathway.
INTERPRETATION
When testing a specific pathway for a specific sample of patients, it is usually not satisfactory to report only the resulting p-value. In this section we will discuss some issues related to the interpretation of the test result. We show how to calculate and visualize the influence of individual genes on the test result. We also propose a diagnostic which can be used when many genes are associated with survival, to assess whether a gene group is exceptional. We only give the theory here; for an example, see Section 5.
Interpretation of the test statistic
The test of this paper is derived from the Cox model in the same way as the Global Test in Goeman et al. (2004) was derived from the generalized linear model. The functional form of the test statistic is therefore quite similar, with the martingale residuals taking the place of the residuals from the generalized linear model in that paper. Much of the interpretation of the test statistic is therefore also quite similar.
Central to all interpretation of the test outcome is the matrix R = XX � which figures prominently in the formula for the test statistic. It is an n × n matrix which can be seen as describing the similarities in the expression profile between the samples. The entry R ij is relatively large if samples i and j have a relatively similar expression profile over the pathway of interest.
To show the role of the matrix R, we can rewrite the unstandardized test statistic T 0 as
labelled and hybridized in duplicate, one sample in triplicate. These technical replicates were averaged after gene expression measures were obtained, which was done using gcrma (15) . No preselection of genes was made. The 17 patients were followed up to 10 years. Median survival time was 40 months. Available covariates included the presence of metastasis at diagnosis, histology and response to neoadjuvant chemotherapy. However, as treatment was not uniform over all patients, these covariates were not prognostic and we did not consider them. Pathway information was obtained from the Gene Ontology (GO) database, using the BioConductor GO package (16) . Pathways that were considered of specific interest were cell cycle (GO: 7049), DNA repair (GO: 6281), Angiogenesis (GO: 1525), Skeletal development (GO: 1501) and Apoptosis (GO: 6915).
Analysis
When testing pathways of interest, it is advisable to also test the 'pathway' of all genes on the chip for association with survival. This shows whether the overall gene expression profile is associated with survival. The results for the pathway of all genes and for the five pathways of primary interest are given in table 1. We calculated the p-value using both the asymptotic theory method and the permutation method (using 100,000 permutations). The permutation p-values tend to be somewhat more conservative than the asymptotic p-values, reflecting both the slight loss of power for the permutation test and a deviation from asymptotic normality due to the small number of samples. In this data set the expression profile over the set of all genes on the chip is significantly associated with survival. Note that this does not mean that every gene on the chip is associated with survival. It means that the patients who die early are relatively similar to each other in Chapter 4 132 terms of their overall expression profile, while patients who live long are likewise relatively similar. It also means that there is some potential for prediction of survival based on gene expression, even before any pre-selection of genes. The cell cycle, DNA repair and apoptosis pathways are clearly associated with survival, while there is no evidence for this association in angiogenesis and skeletal development. Because the test for all genes was significant, we expect a sizeable proportion of genes to be associated with survival, so that many pathways will be associated with survival. The comparative p gives a measure whether the p-value found for the pathway is unusually low given that it is a pathway of its size from this data set (see section 8.3). For the results in table 1 10,000 gene sets were sampled for each pathway. We used the asymptotic p-values for the comparative p calculations. We conclude that cell cycle and DNA repair are more clearly associated than could be expected from a gene set of its size in this data set: only around 60 out of 10,000 random gene sets of size 1,115 have a lower p-value than the cell cycle pathway. The expression profile of the apoptosis pathway is clearly associated with survival, as can be seen from the p-values; however it is not exceptional in that: more than 20% of random gene sets have a lower p-value than apoptosis. The Skeletal development pathway is interesting in its own way: it is clearly not associated with survival ( 0.5 = p ) and this is quite exceptional for a pathway of this size in this data set: only around 20 in 10,000 random gene sets had a higher p-value. The skeletal development pathway seems to include uncommonly few genes which are associated with survival. It can occur in some data sets that the set of all genes is not significant, while some pathways (eg. DNA repair) are significant. This occurs in table 1 for example if we use FDR-adjusted p-values with a threshold of 0.01 (17) . The result for all genes can be seen as a false negative test result. However, another valid interpretation is that prediction of survival without biological pre-selection of genes is uncertain, but if it is known a priori that the genes in the DNA repair pathway are likely to be informative, some prediction of survival is possible.
Mining the GO database
If it is not a priori known which pathways are of specific interest, one can also use a datamining approach, trying to find those pathways which are most significantly associated with survival. For the osteosarcoma data we explored the Gene Ontology database. Of all GO terms, 4,032 matched at least one gene on the hu133a chip. We excluded all terms which matched only one gene, because the interesting single genes pathways would already have been found in single gene testing. This left 3,080 pathways, which we all tested for association with survival. We used the asymptotic p-value, because due to the randomness in the the permutation p-value it does not give a unique list. Table 2 gives the ten GO-terms with the smallest p-values. To adjust for multiple testing, one can use the Benjamini and Hochberg FDR (17) . All 10 pathways in table 2 are significant on an FDR of 0.05. The p-values of the pathways tend to 
INTERPRETATION
Interpretation of the test statistic
The test of this paper is derived from the Cox model in the same way as the Global Test in Goeman et al. (2004) was derived from the generalized linear model. The functional form of the test statistic is therefore quite similar, with the martingale residuals taking the place of the residuals from the generalized linear model in that paper. Much of the interpretation of the test statistic is therefore also quite similar. Central to all interpretation of the test outcome is the matrix R = XX � which figures prominently in the formula for the test statistic. It is an n × n matrix which can be seen as describing the similarities in the expression profile between the samples. The entry R ij is relatively large if samples i and j have a relatively similar expression profile over the pathway of interest.
of the latter matrix is large whenever samples i and j have similar martingale residuals. The test statistic T 0 is therefore relatively large whenever the entries of the matrices R and (d −û)(d −û) � are correlated, which is when similarity in gene expressions tends to coincide with similarity in the martingale residual. Hence, the test statistic is large if individuals who die sooner than expected tend to be relatively similar in their gene expression profiles and individuals who live longer than expected also tend to be similar in their gene expression profiles.
Gene plot
To investigate the influence of individual genes on the test outcome we can rewrite R = 
discussion
It has often been remarked that the key to successful microarray data analysis lies in an intelligent integration of advanced statistical methods with the vast domain of biological knowledge that is already available. The global test for survival presented in this paper is a step forward in this direction, combining known biological pathway information with the statistical sophistication of the Cox proportional hazards model. Due to its complexity the Cox model has been slow to find its way to microarray methodology. Most methods require survival to be reduced to a two-valued variable, using an arbitrary cut-off, resulting in unnecessary loss of information. By using the Cox model for survival, gene expression analysis can improve performance and also become better connected to traditional medical statistics.
Pathway information is available from many databases and is essential for the understanding of the outcomes of a microarray experiment. The Global Test methodology allows researchers to look directly for important pathways, without first having to go through single gene testing. This may lead to a better use of pathway information and more directly interpretable results.
